Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Operating Income: 2018-2024

Historic Operating Income for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to -$59.9 million.

  • Gossamer Bio's Operating Income fell 44.80% to -$49.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$160.8 million, marking a year-over-year decrease of 120.85%. This contributed to the annual value of -$59.9 million for FY2024, which is 67.39% up from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Operating Income is -$59.9 million, which was up 67.39% from -$183.8 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Operating Income registered a high of -$59.9 million during FY2024, and its lowest value of -$234.0 million during FY2020.
  • Over the past 3 years, Gossamer Bio's median Operating Income value was -$183.8 million (recorded in 2023), while the average stood at -$154.1 million.
  • Per our database at Business Quant, Gossamer Bio's Operating Income dropped by 25.69% in 2020 and then surged by 67.39% in 2024.
  • Gossamer Bio's Operating Income (Yearly) stood at -$234.0 million in 2020, then rose by 7.62% to -$216.1 million in 2021, then fell by 1.14% to -$218.6 million in 2022, then grew by 15.94% to -$183.8 million in 2023, then skyrocketed by 67.39% to -$59.9 million in 2024.